结核病短程治疗研究:回顾与展望OA北大核心CSTPCD

The global decline in tuberculosis(TB)incidence has been disappointingly slow,significantly lagging behind the milestones set by the World Health Organization's End TB Strategy.Consequently,the development and implementation of effective short-course treatment regimens have become imperative.This review aims to examine the progress of short-course TB treatments over the past few decades and evaluate the efficacy of current therapeutic approaches,providing essential references and support for optimizing future treatment strategies.Through a systematic review of the literature and the latest clinical trial data,we analyzed the efficacy,safety,and application scenarios of various short-course treatment regimens.Furthermore,we summarized the main strategies for current short-course treatments.Despite existing challenges,significant progress in tuberculosis short-course treatment is anticipated in the coming years,driven by the development of novel drugs,dose optimization,and more precise patient evaluation.